Development of a mouse model for assessing fatigue during chemotherapy

Comparative Medicine

Volumn 61, Issue 2, 2011, Pages 119-130

  Ray, Maria A ^a   Trammell, Rita A ^a   Verhulst, Steve ^a   Ran, Sophia ^a   Toth, Linda A ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 12P75; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NANOPARTICLE; PACLITAXEL; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL COUNT; CAGE; CANCER CHEMOTHERAPY; CANCER FATIGUE; CONTROLLED STUDY; CORE TEMPERATURE; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG MONITORING; DRUG POTENCY; FEMALE; LOCOMOTION; MALE; MAXIMUM TOLERATED DOSE; MOTOR DYSFUNCTION; MOUSE; NEUROLOGIC EXAMINATION; NEUROTOXICITY; NEUTROPENIA; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; SLEEP PATTERN; TREADMILL EXERCISE; TREATMENT DURATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CIRCADIAN RHYTHM; DRUG THERAPY; FATIGUE; NEOPLASM; SLEEP;

ANIMALS; CIRCADIAN RHYTHM; DRUG THERAPY; FATIGUE; FEMALE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MODELS, ANIMAL; NANOPARTICLES; NEOPLASMS; NEUROLOGIC EXAMINATION; PACLITAXEL; SLEEP;

EID: 80052543368     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ancoli-Israel S. 2001. The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care (Engl) 10:245-255. (Pubitemid 33699428)
2. Bower JE, Ganz PA, Desmond KA, Bernaards C, Rowland JH, Meyerowitz BE, Belin TR. 2006. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer 106:751-758. (Pubitemid 43238440)
3. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. 2000. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743-753. (Pubitemid 30106604)
4. Cleeland CS, Bennett GJ, Dantzer R, Dougherty PM, Dunn AJ, Meyers CA, Miller AH, Payne R, Reuben JM, Wang XS, Lee BN. 2003. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 97:2919-2925. (Pubitemid 36605163)
5. Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR. 2006. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 12:2759-2766.
6. Damascelli B, Cantu G, Mattavelli F, Tamplenizza P, Bidoli P, Leo E, Dosio F, Cerrotta AM, DiTolla G, Frigerio LF, Garbagnati F, Lanocita R, Marchiano A, Patelli G, Spreafico C, Ticha V, Vespro V, Zunino F. 2001. Intraarterial chemotherapy with polyoxyethylated castor-oil-free paclitaxel, incorporated in albumin nanoparticles (ABI-007): Phase II study of patients with squamous cell carcinoma of the head and neck and anal canal: preliminary evidence of clinical activity. Cancer 92:2592-2602. (Pubitemid 33049443)
7. Desai N, Trieu V, Yao Z, Louie L, Ci S, Yang A, Tao C, De T, Beals B, Dykes D, Noker P, Yao R, Labao E, Hawkins M, Soon- Shiong P. 2006. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophorbased paclitaxel. Clin Cancer Res 12:1317-1324. (Pubitemid 43342524)
8. Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence HH. 2002. Sleep and quality of life in breast cancer patients. J Pain Symptom Manage 24:471-480. (Pubitemid 36120423)
9. Gelderblom H, Verweij J, Nooter K, Sparreboom A. 2001. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 37:1590-1598. (Pubitemid 32778603)
10. Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, Hawkins M, O'Shaughnessy J. 2005. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol 23:7794-7803. (Pubitemid 46657376)
11. Harkin A, Houlihan DD, Kelly JP. 2002. Reduction in preference for saccharin by repeated unpredictable stress in mice and its prevention by imipramine. J Psychopharmacol 16:115-123. (Pubitemid 34614880)
12. Hayes KE, Raucci JR, Gades NM, Toth LA. 2000. An evaluation of analgesic regimens for abdominal surgery in mice. Contemp Top Lab Anim Sci 39:18-23.
13. Hewitt JA, Mokbel K, van Someren KA, Jewell AP, Garrod R. 2005. Exercise for breast cancer survival: the effect on cancer risk and cancer-related fatigue (CRF). Int J Fertil Womens Med 50:231-239. (Pubitemid 46638706)
14. Ibrahim NK, Desai N, Legha S, Soon-Shiong P, Theriault RL, Rivera E, Esmaeli B, Ring SE, Bedikian A, Hortobagyi GN, Ellerhorst JA. 2002. Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res 8:1038-1044. (Pubitemid 34517637)
15. Jereczek-Fossa BA, Marsiglia HR, Orecchia R. 2002. Radiotherapyrelated fatigue. Crit Rev Oncol Hematol 41:317-325.
16. Kawasaki K, Akashi S, Shimazu R, Yoshida T, Miyake K, Nishijima M. 2001. Involvement of TLR4/MD2 complex in species-specific lipopolysaccharide-mimetic signal transduction by Taxol. J Endotoxin Res 7:232-236. (Pubitemid 32894579)
17. Kuchinski AM, Reading M, Lash AA. 2009. Treatment-related fatigue and exercise in patients with cancer: a systematic review. Medsurg Nurs 18:174-180.
18. Lee JJ, Swain SM. 2006. Peripheral neuropathy induced by microtubule- stabilizing agents. J Clin Oncol 24:1633-1642. (Pubitemid 46638788)
19. Letourneau PC, Shattuck TA, Ressler LH. 1986. Branching of sensory and sympathetic neurites in vitro is inhibited by treatment with taxol. J Neurosci 6:1912-1917. (Pubitemid 16064955)
20. Levi F. 2006. Chronotherapeutics: the relevance of timing in cancer therapy. Cancer Causes Control 17:611-621.
21. Marupudi NI, Han JE, Li KW, Renard VM, Tyler BM, Brem H. 2007. Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin Drug Saf 6:609-621. (Pubitemid 351308218)
22. Monleon S, D'Aquila P, Parra A, Simon VM, Brain PF, Willner P. 1995. Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology (Berl) 117:453-457.
23. Mystakidou K, Parpa E, Tsilika E, Pathiaki M, Patiraki E, Galanos A, Vlahos L. 2007. Sleep quality in advanced cancer patients. J Psychosom Res 62:527-533. (Pubitemid 46656381)
24. Nyman DW, Campbell KJ, Hersh E, Long K, Richardson K, Trieu V, Desai N, Hawkins MJ, Von Hoff DD. 2005. Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies. J Clin Oncol 23:7785-7793. (Pubitemid 46657375)
25. O'Brien JM Jr, Wewers MD, Moore SA, Allen JN. 1995. Taxol and colchicine increase LPS-induced proIL1β production, but do not increase IL1β secretion. A role for microtubules in the regulation of IL1β production. J Immunol 154:4113-4122.
26. Pollmacher T, Haack M, Schuld A, Reichenberg A, Yirmiya R. 2002. Low levels of circulating inflammatory cytokines-do they affect human brain functions? Brain Behav Immun 16:525-532. (Pubitemid 35333732)
27. Pusztai L, Mendoza TR, Reuben JM, Martinez MM, Willey JS, Lara J, Syed A, Fritsche HA, Bruera E, Booser D, Valero V, Arun B, Ibrahim N, Rivera E, Royce M, Cleeland CS, Hortobagyi GN. 2004. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine 25:94-102. (Pubitemid 38096266)
28. Ray M, Rogers LQ, Trammell RA, Toth LA. 2008. Fatigue and sleep during cancer and chemotherapy: translational rodent models. Comp Med 58:234-245. (Pubitemid 351954729)
29. Schubert C, Hong S, Natarajan L, Mills PJ, Dimsdale JE. 2007. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun 21:413-427. (Pubitemid 46528677)
30. Schweizer MC, Henninger MS, Sillaber I. 2009. Chronic mild stress (CMS) in mice: of anhedonia, 'anomalous anxiolysis,' and activity. PLoS ONE 4:e4326.
31. Sheng WS, Hu S, Lamkin A, Peterson PK, Chao CC. 1996. Susceptibility to immunologically mediated fatigue in C57BL/6 versus Balb/c mice. Clin Immunol Immunopathol 81:161-167. (Pubitemid 26393660)
32. Tisdale MJ. 2002. Cachexia in cancer patients. Nat Rev Cancer 2:862-871. (Pubitemid 37328904)
33. Toth LA, Rehg JE, Webster RG. 1995. Strain differences in sleep and other pathophysiological sequelae of influenza virus infection in naive and immunized mice. J Neuroimmunol 58:89-99.
34. Toth LA, Verhulst SJ. 2003. Strain differences in sleep patterns of healthy and influenza-infected inbred mice. Behav Genet 33: 325-336. (Pubitemid 36638002)
35. Volk LD, Flister MJ, Bivens CM, Stutzman A, Desai N, Trieu V, Ran S. 2008. Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent antivascular endothelial growth factor A therapy. Neoplasia 10:613-623. (Pubitemid 351770305)
36. Wang AC, Su QB, Wu FX, Zhang XL, Liu PS. 2009. Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells. Eur J Clin Invest 39:157-164.
37. Winer EP, Berry DA, Woolf S, Diggan D, Kombith A, Harris LN, Michaelson RA, Kirshner JA, Fleming GF, Perry MC, Graham ML, Sharp SA, Kereztes R, Henderson IC, Hudis C, Muss H, Norton L. 2004. Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: Cancer and Leukemia Group B trial 9342. J Clin Oncol 22:2061-2068. (Pubitemid 41095138)
38. Wood LJ, Nail LM, Perrin NA, Elsea CR, Fischer A, Drucker BJ. 2006. The cancer chemotherapy drug etoposide (VP16) induces proinflammatory cytokine production and sickness behavior-like symptoms in a mouse model of cancer chemotherapy-related symptoms. Biol Res Nurs 8:157-169. (Pubitemid 44410365)
39. Zaks-Zilberman M, Zaks TZ, Vogel SN. 2001. Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol) in murine and human breast cancer cell lines. Cytokine 15:156-165. (Pubitemid 34587497)